Modulation of airway responses by prostaglandins in young and fully grown rabbits

American Journal of Physiology - Lung Cellular and Molecular Physiology

Volumn 293, Issue 1, 2007, Pages

  Larsen, Gary L ^a   Loader, Joan ^a   Fratelli, Cori ^a   Kang, June Ku Brian ^a   Dakhama, Azzeddine ^a   Colasurdo, Giuseppe N ^b  

^a NATIONAL JEWISH MEDICAL AND RESEARCH CENTER   (United States)

^b UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

Author keywords

Airway development; Bronchoprotection; Prostacyclin; Prostaglandin E 2; Relaxant responses of airways

Indexed keywords

6 OXOPROSTAGLANDIN F1 ALPHA; BUFFER; INDOMETACIN; NEUROKININ A; PROSTACYCLIN; PROSTAGLANDIN; PROSTAGLANDIN E2; PROSTAGLANDIN INHIBITOR;

AIRWAY; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; ELECTROSTIMULATION; IMMUNOMODULATION; LUNG DEVELOPMENT; METABOLITE; MODULATION; MUSCLE CONTRACTILITY; MUSCLE RELAXATION; NONHUMAN; PRIORITY JOURNAL; PROTECTION; RABBIT; RESPIRATORY SYSTEM; TRACHEA;

6-KETOPROSTAGLANDIN F1 ALPHA; ANIMALS; DINOPROSTONE; ELECTRIC STIMULATION; MUSCLE CONTRACTION; MUSCLE RELAXATION; MUSCLE, SMOOTH; PROSTAGLANDINS; RABBITS; TRACHEA;

EID: 34447529268     PISSN: 10400605     EISSN: 15221504     Source Type: Journal    
DOI: 10.1152/ajplung.00413.2006     Document Type: Article

References (40)

1. Bellinger DL, Lorton D, Brouxhon S, Felten S, Felten DL. The significance of vasoactive intestinal peptide (VIP) in immunomodulation. Adv Neurol 6: 5-27, 1996.
2. 2 might be mediated by increased numbers of E-prostanoid receptors. J Allergy Clin Immunol 113: 876-881, 2004.
3. Cardell LO, Uddman R, Edvinsson L. Low plasma concentrations of VIP and elevated levels of other neuropeptides during exacerbations of asthma. Eur Respir J 7: 2169-2173, 1994.
4. Carey MA, Germolec DR, Langenbach R, Zeldin DC. Cyclooxygenase enzymes in allergic inflammation and asthma. Prostaglandins Leukot Essent Fatty Acids 69: 157-162, 2003.
5. Colasurdo GN, Loader JE, Graves JP, Larsen GL. Maturation of nonadrenergic noncholinergic inhibitory system in normal and allergen-sensitized rabbits. Am J Physiol Lung Cell Mol Physiol 267: L739-L744, 1994.
6. Colasurdo GN, Loader JE, Graves JP, Larsen GL. Modulation of acetylcholine release in rabbit airways in vitro. Am J Physiol Lung Cell Mol Physiol 268: L432-L437, 1995.
7. Doidge JM, Satchell DG. Adrenergic and non-adrenergic inhibitory nerves in mammalian airways. J Auton Nerv Syst 5: 83-99, 1982.
8. 2 in human bronchi. Am J Respir Crit Care Med 154: 244-246, 1996.
9. Fame TM, Colasurdo GN, Loader JE, Graves JP, Larsen GL. Decrease in the airways' nonadrenergic noncholinergic inhibitory system in allergen sensitized rabbits. Pediatr Pulmonol 17: 296-303, 1994.
10. Fernandes LB, Hubbard WC, Undem BJ. Release of inflammatory mediators from guinea pig trachea by electrical field stimulation: lack of neuronal involvement. J Pharmacol Exp Ther 270: 1166-1170, 1994.
11. 2 on allergen-induced airway responses and airway inflammation. Am J Respir Crit Care Med 159: 31-36, 1999.
12. Gelfand AS, Larsen GL, Loader JE, Fan LL, Colasurdo GN. Effects of aspiration of milk on mechanisms of neural control in the airways of developing rabbits. Pediatr Pulmonol 23: 198-204, 1997.
13. Geppetti P, De Rossi M, Mione MC, Renzi D, Amenta F. Age-related changes in vasoactive intestinal polypeptide levels and distribution in the rat lung. J Neural Transm 74: 1-10, 1988.
14. Groneberg DA, Springer J, Fischer A. Vasoactive intestinal polypeptide as mediator of asthma. Pulm Pharmacol Ther 14: 391-401, 2001.
15. Hallstrand TS, Moody MW, Aitken ML, Henderson WR Jr. Airway immunopathology of asthma with exercise-induced bronchoconstriction. J Allergy Clin Immunol 116: 586-593, 2005.
16. Hallstrand TS, Moody MW, Wurfel MM, Schwartz LB, Henderson WR Jr, Aitken ML. Inflammatory basis of exercise-induced bronchoconstriction. Am J Respir Crit Care Med 172: 679-686, 2005.
17. Hardy CC, Bradding P, Robinson C, Holgate ST. Bronchoconstrictor and antibronchoconstrictor properties of inhaled prostacyclin in asthma. J Appl Physiol 64: 1567-1574, 1988.
18. 2 protects lower airways against bronchoconstriction. Am J Physiol Lung Cell Mol Physiol 290: L105-L113, 2006.
19. Hislop AA, Wharton J, Allen KM, Polak JM, Haworth SG. Immunohistochemical localization of peptide-containing nerves in human airways: age-related changes. Am J Respir Cell Mol Biol 3: 191-198, 1990.
20. Joos GF, Germonpré PR, Pauwels RA. Role of tachykinins in asthma. Allergy 55: 321-337, 2000.
21. 2α reduce exhaled nitric oxide in normal and asthmatics subjects irrespective of airway caliber changes. Am J Respir Crit Care Med 158: 1374-1378, 1998.
22. Larsen GL, Colasurdo GN. Neural control mechanisms within airways: disruption by respiratory syncytial virus. J Pediatr 135: S21-S27, 1999.
23. Larsen GL, Fratelli C, Loader J, Kang JK, Dakhama A. Neuropeptide release from airways of young and fully-grown rabbits. Pediatr Pulmonol 41: 1242-1249, 2006.
24. Larsen GL, Loader J, Fratelli C, Kang JK, Dakhama A, Colasurdo GN. Phosphodiesterase IV and neutral endopeptidase in airways from developing and allergen sensitized rabbits. Pulm Pharmacol Ther 19: 335-342, 2006.
25. Larsen GL, Loader J, Nguyen DD, Colasurdo GN. Mechanisms of cholinergic dysfunction in rabbits following recurrent aspiration of cow's milk. Pediatr Pulmonol 32: 409-417, 2001.
26. Larsen GL, Loader J, Nguyen DD, Fratelli C, Dakhama A, Colasurdo GN. Mechanisms determining cholinergic neural responses in airways of young and mature rabbits. Pediatr Pulmonol 38: 97-106, 2004.
27. McGrogan I, Daniel EE. Release and actions of inhibitory prostaglandins from canine tracheal epithelium. Can J Physiol Pharmacol 74: 1055-1060, 1996.
28. 2 on exercise-induced bronchoconstriction in asthmatic subjects. Am J Respir Crit Care Med 149: 1138-1141, 1994.
29. Narumiya S, Sugimoto Y, Ushikubi F. Prostanoid receptors: structures, properties, functions. Physiol Rev 79: 1193-1226, 1999.
30. Norel X, Walch L, Labat C, Gascard JP, Dulmet E, Brink C. Prostanoid receptors involved in the relaxation of human bronchial preparations. Br J Pharmacol 126: 867-872, 1999.
31. 2. Lancet 345: 436-438, 1995.
32. 2 on allergen-induced asthma. Am Rev Respir Dis 148: 87-90, 1993.
33. 4 excretion in aspirin-sensitive asthma. Am J Respir Crit Care Med 153: 572-575, 1996.
34. 3-subtype. Br J Pharmacol 123: 1246-1252, 1998.
35. 2 receptor selective agonists E-prostanoid 2 and E-prostanoid 4 may have therapeutic effects on ovalbumin-induced bronchoconstriction. Chest 128: 3717-3723, 2005.
36. 2 on airway tone. Am J Physiol Lung Cell Mol Physiol 284: L599-L606, 2003.
37. 2 induced by electrical field stimulation in isolated ferret trachea. Am J Respir Cell Mol Biol 4: 243-247, 1991.
38. Wenzel SE, Westcott JY, Smith HR, Larsen GL. Spectrum of prostanoid release after bronchoalveolar allergen challenge in atopic asthmatics and in control groups. An alteration in the ratio of bronchoconstrictive to bronchoprotective mediators. Am Rev Respir Dis 139: 450-457, 1989.
39. Ying S, Meng Q, Scadding G, Parikh A, Corrigan CJ, Lee TH. Aspirin-sensitive rhinosinusitis is associated with reduced E-prostanoid 2 receptor expression on nasal mucosal inflammatory cells. J Allergy Clin Immunol 117: 312-318, 2006.
40. 2 receptor subtypes on cells in sputum from patients with asthma and controls: effects of allergen inhalational challenge. J Allergy Clin Immunol 114: 1309-1316, 2004.